Cardiac Damage in Rodents after Exposure to Bis(2-chloroethoxy)methane

Toxicologic Pathology

Volumn 32, Issue 3, 2004, Pages 309-317

  Dunnick, June K ^a   Lieuallen, Warren ^b   Moyer, Carolyn ^b   Orzech, Denise ^a   Nyska, Abraham ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b CHARLES RIVER LABORATORIES   (United States)

Author keywords

Bis(2 chloroethoxy)methane; cardiotoxictiy; mitochondrial dysfunction; mouse; myocyte vacuolization; rat; troponin T

Indexed keywords

BIS(2 CHLOROETHOXY)METHANE; METHANE; TROPONIN T; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOTOXICITY; CAUSE OF DEATH; CELL DEATH; CELL INFILTRATION; CELL VACUOLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; FEMALE; HEART ATRIUM THROMBOSIS; HEART INJURY; HEART MUSCLE CELL; HISTOPATHOLOGY; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TOXICITY TESTING;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHYL ETHERS; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MICE; MITOCHONDRIA; MYOCARDIUM; RATS; SEX FACTORS; SOLVENTS; SPECIES SPECIFICITY; TROPONIN T;

ANIMALIA; RODENTIA; VERTEBRATA;

EID: 2542470535     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230490431501     Document Type: Article

References (44)

1. Antman, E.M. (2002). Decision making with cardiac troponin tests [editorial]. N Engl J Med 346, 2079-82.
2. Apple, F.S. (2001). Cardiac Troponin Assays: Analytical issues and clinical reference range cutpoints. Cardiovasc Toxicol 1, 93-8.
3. Bernat, A., and Herbert, J.M. (1994). Effect of various drugs on adriamycin-enhanced venous thrombosis in the rat: Importance of PAF. Thromb Res 75, 91-7.
4. Bleuel, H., Deschl, U., Bertsch, T., Bolz, G., and Rebel, W. (1995). Diagnostic efficiency of troponin T measurements in rats with experimental myocardial cell damage. Exp Toxicol Pathol 47, 121-7.
5. Childs, A.C., Phaneuf, S.L., Dirks, A.J., Phillips, T., and Leeuwenburgh, C. (2002). Doxorubicin treatment in vivo causes cytochrome c release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. Cancer Res 62, 4592-8.
6. Dunn, O.J. (1964). Multiple comparisons using rank sums. Technometrics 6, 241-52.
7. Dunnett, W. (1955). A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50, 1095-121.
8. Environmental Protection Agency (2003). High Production Volume Chemical List. 〈http://www.epa.gov/chemrtk/hpvchmlt.htm〉.
9. Fujihira, S., Yamamoto, T., Matsumoto, M., Yoshizawa, K., Oishi, Y., Fugii, T., Noguchi, H., and Mori, H. (1993). The high incidence of atrial thrombosis in mice given doxorubicin. Toxicol Pathol 21, 362-8.
10. Green, T., and Hathway, D.E. (1975). The biological fate in rats of vinyl chloride in relation to its oncogenicity. Chem Biol Interact 11, 545-62.
11. Grossblatt, N. (1996). Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC.
12. Hazardous Substance Database (2002). Hazardous Substances Databases, National Institute of Occupational Safety and Health, Washington, DC. 〈http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB〉.
13. Herman, E.H., El-Hage, A.N., Ferrans, V.J., and Ardalan, B. (1985). Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive rats. Toxicol Appl Pharmacol 78, 202-14.
14. Herman, E.H., Lipshultz, S.E., Rifai, N., Zhang, J., Papoian, T., Yu, Z.X., Takeda, K., and Ferrans, V.J. (1998). Use of cardiac troponin T levels as an indicator of doxorubinin-induced cardiotoxicity. Cancer Res 58, 195-7.
15. Herman, E.H., Zhang, J., Chadwick, D.P., and Ferrans, V.J. (1996). Age dependence of the cardiac lesiosn induced by minoxidil in the rat. Toxicology 110, 71-83.
16. Herman, E.H., Zhang, J., Chadwick, D.P., and Ferrans, V.J. (2000). Comparison of the protective effects of amifostine and dexrazoxane against the toxicty of doxorubicin in spontaneously hypertensive rats. Cancer Chemother Pharmacol 45, 329-34.
17. Herman, E.H., Zhang, J., Lipshultz, S.E., Rifai, N., Chadwick, D.P., Takeda, K., Yu, Z.X., and Ferrans, V.J. (1999). Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. J Clin Oncol 17, 2237-43.
18. Hopkins, P.N., and Williams, R.R. (1981). A survey of 246 suggested coronary risk factors. Atherosclerosis 40, 1-52.
19. Hsu, S., and Raine, L. (1981). Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem 29, 1349-53.
20. Jin, J.P., Huang, Q.A., Yeh, H.I., and Lin, J.J.C. (1992). Complete nucleotide sequence and structural organization of rat cardiac troponin T gene. J Mol Biol 227, 1269-76.
21. Jones, B.K., and Hathway, D.E. (1978). Differences in metabolism of vinylidene chloride between mice and rats. Br J Cancer 37, 411-7.
22. Katus, H.A., Looser, S., Hallermayer, K., Remppis, A., Scheffold, T., Borgya, A., Essig, U., and Geuss, U. (1992). Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clinic Chem 38, 383-93.
23. Katus, H.A., Remppis, A., Neumann, F.J., Scheffold, T., Diederich, K.W., Vinar, G., Noe, A., Matern, G., and Kuebler, W. (1991). Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 83, 902-12.
24. Kragten, J.A. (1996). Cardiac troponin T release into plasma after acute myocardial infarction: Only fractional recovery compared with enzymes. Ann Clin Biochem 33, 314-23.
25. Lesnefsky, E.J., Moghaddas, S., Tandler, B., Kerner, J., and Hoppel, C.L. (2001). Mitochondrial dysfunction in cardiac disease: Ischemia-reperfusion, aging, and heart failure. J Mol Cell Cardiol 33, 1065-89.
26. Marin-Garcia, J., and Goldenthal, M.J. (2002). Understanding the impact of mitochondrial defects in cardiovascular disease: A review. J Card Failure 8, 347-60.
27. Mathews, J.M., and Jeffcoat, A.R. (2002). Bis(2-chloroethoxy)methane: Comparative metabolism and excretion in rats and mice. NIEHS Contract No. N01-ES-75407 contract with RTI, Research Triangle Park, NC RTI Report No. RTI/64U-6855/14P, Feb 28, 2002.
28. Mesnard, L., Samson, F., Espinasse, I., Durand, J., Neveux, J., and Mercadier, J. (1993). Molecular cloning and development expression of human cardiac troponin T. Fed Eur Biochem Soc 328, 139-44.
29. National Toxicology Program (1992). Toxicology and Carcinogenesis Studies of Monochloroacetic Acid in F344/N rats and B6C3F1 mice. Research Triangle Park, NC.
30. National Toxicology Program (2000). Bulk chemical limited analysis report, bis(2-chloroethoxy)methane. NIH Contract No. N01-ES-55397, Task CHEM04776.
31. National Toxicology Program (2002). 90-day toxicity studies of bis(2-chloroethoxy)methane. Battelle Columbus reports submitted to NTP-G004164-AD & G004164-AE, July and October 2002.
32. O'Brien, P.J., Dameron, G.W., Beck, M.L., Kang, Y.J., Erickson, B.K., Di Battista, T.H., Miller, K.E., Jackson, K.N., and Mittelstadt, S. (1997). Cardiac troponin T is a sensitive, specific, biomarker of cardiac injury in laboratory animals. Lab Anim Sci 47, 486-95.
33. Ohman, E.M., Armstrong, P.W., Christenson, R.H., Granger, C.B., Katus, H.A., Hamm, C.W., O'Hanesian, M.A., Wagner, G.S., Kleiman, N.S., Harrell, F.E., Jr., Califf, R.M., Topol, E.J., and Gusto-Ila Investigators. (1996). Cardiac troponin T levels for risk stratification in acute myocardial ischemia. NEJM 335, 1333-41.
34. Pearlstone, J.R., Carpenter, M.R., and Smillie, L.B. (1986). Amino acid sequences of rabbit cardiac troponin T. J Biol Chem 261, 16795-810.
35. Raggi, A., Grand, R.J.A., Moir, A.J.G., and Perry, S.V. (1989). Structure-function relationships in cardiac troponin T. Biochim Biophys Acta 997, 135-43.
36. Ruben, Z., Arceo, R.J., Bishop, S.P., Elwell, M.R., Kerns, W.D., Mesfin, G.M., Sandusky, G.E., and Van Vleet, J.F. (2000). Non-proliferative lesions of the heart and vasculature in rats. CV-1. Guides for Toxicologic Pathology, pp. 1-10. STP/ARP/AFIP.
37. Shirley, E. (1977). A non-parametric equivalent of William's test for contrasting increasing dose levels of a treatment. Biometrics 33, 386-9.
38. Sorescu, D., and Griendling, K.K. (2002). Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest Heart Fail 8, 132-40.
39. The Joint European Society of Cardiology/American College of Cardiology Committee (2000). Myocardial infaction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infaction. Europ Heart J 21, 1502-13.
40. van Loo, G., Saelens, X., van Gurp, M., MacFarlane, M., Martin, S.J., and Vandenabelle, P. (2002). The role of mitochondrial factors in apoptosis: A Russian roulette with more than one bullet. Cell Death Differ 9, 1031-42.
41. Visarius, T.M., Bahler, H., Kupfer, M.A., Cerny, T., and Lauterburg, B.H. (1998). Thiodiglycolic acid is excreted by humans receiving ifosfamide and inhibits mitochondrial function in rats. Drug Metab Disp 26, 193-6.
42. Wang, X. (2001). The expanding role of mitochondria in apoptosis. Genes Dev 15, 2922-2933.
43. Yllner, S. (1971). Metabolism of chloracetate-1-14C in the mouse. Acta Pharmacol Toxicol 30, 69-80.
44. Yussman, M.G., Toyokawa, T., Odley, A., Lynch, R.A., Wu, G., Colbert, M.C., Aronow, B.J., Lorenz, J.N., and Dorn, G.W.I. (2002). Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy. Nat Med 8, 725-30.